<
public policy
< legislative
update
Legislative
Counsel Announcement
Political
Landscape
The
most significant political event of the first
session of the 107th Congress was the decision
by Vermont Senator James Jeffords to leave the
Republican Party to become an independent and
caucus with the Democrats on organizational matters.
This decision, which Senator Jeffords made because
he felt the Republican Party had become too conservative,
thrust the Democrats into control of the evenly
divided Senate.
Senate
Majority Leader Tom Daschle (D-SD) brought the
patients' bill of rights to the Senate floor as
his first action as majority leader. The Senate
would probably have not considered this bill as
quickly if the Democrats were not in power. In
addition, the shift in power in the Senate should
slow the annual appropriations process, as Senate
Democrats will use every tactic at their disposal
to try and demonstrate that President Bush's tax
cut was excessive and greatly reduced the federal
surplus.
The
House of Representatives is also closely divided
and there are currently several vacancies. Rep.
Joe Moakley (D-MA) passed away in late May, while
Rep. Floyd Spence (R-SC) died in mid-August. These
seats are expected to remain in the Democrat and
Republican columns, respectively. In addition,
Rep. Asa Hutchinson (R-AR) was tapped by President
Bush to head the Drug Enforcement Administration.
That leaves the current ratio in the House at
220 Republicans, 210 Democrats, and 2 independents.
Also, Rep. Steve Largent (R-OK) will retire on
November 29 to run for governor, while Rep. Joe
Scarborough (R-FL) will resign for personal reasons
in September. This will leave the House GOP with
a tenuous majority over the next several months,
and means that a solid Democratic caucus need
only peel off a few moderate Republicans in order
to prevail on any given vote.
Patients'
Bill of Rights
Both
the House of Representatives and Senate passed
legislation this summer to enact a patients' bill
of rights. Lawmakers are now preparing for a House-Senate
conference committee, where they will once again
attempt to reconcile the two bills and send a
consensus bill to the president.
The
Senate
The
Senate began consideration of patients' rights
legislation in mid-June, shortly after the Democrats
took over as the majority party. S. 1052, the
Bipartisan Patient Protection Act of 2001,
introduced by Senators John McCain (R-AZ), John
Edwards (D-NC), and Edward Kennedy (D-MA), was
the subject of contentious debate for almost two
weeks. S. 1052 contains strong patient protections,
including access to specialists, a point-of-service
option, and strong internal and external appeals
processes. ATRA worked with congressional staff
on the drafting of the bill, and endorsed the
final product.
The
debate in the Senate largely centered on the liability
provisions contained in S. 1052. Republicans argued
that these provisions would lead to a rash of
frivolous lawsuits, drive up healthcare costs,
and force employers to drop health insurance coverage.
Republicans offered several amendments largely
centered on efforts to reduce employer liability
and increase state flexibility in enforcing the
federal patient protections. While Democrats and
a few moderate Republicans were able to fend off
these weakening amendments, several compromise
amendments were adopted which ultimately improved
the bill.
These
amendments: 1) would repeal the liability provisions
in the McCain-Edwards-Kennedy bill if more than
one million individuals lose their health insurance
during the first year the law is in effect; 2)
clarify that health plans cannot be required by
an external reviewer to provide coverage for specifically
excluded items or services from an insurance contract
while ensuring that external reviewers have wide
discretion in determining whether or not an item
or service is medically necessary; 3) modify the
standard a state must meet in seeking to opt out
of the federal patients' rights law; and 4) amend
the liability provisions to effectively shield
94% of employers from liability - only large,
self-insured plans would still be open to liability
if they directly participate in a medical decision
to deny care.
The
final bill passed the Senate by a margin of 59-36,
with nine Republicans joining all 50 Democrats
in voting for final passage. Although several
substantive changes were made to the bill in an
attempt to allay Republican concerns, President
Bush reiterated his threat to veto the legislation.
The
House
The
House began consideration of S. 1052 one month
after the Senate finished its work. Rep. Ernie
Fletcher (R-KY) drafted a narrower measure that
had the support of House GOP congressional leaders
and President Bush. However, supporters of the
Fletcher bill were unable to convince enough House
Republicans to support their bill and abandon
the bipartisan bill they had supported in the
past.
It
appeared that House Republican leadership would
be forced to allow the patients' rights debate
to go forward on the House floor with the very
real chance that the companion bill to S. 1052,
introduced by Reps. Greg Ganske (R-IA), John Dingell
(D-MI), Charlie Norwood (R-GA), and Marion Berry
(D-AR) would prevail. Under that scenario, President
Bush would have been forced to either sign a bill
he opposed or veto popular legislation.
That
situation was averted, however, when the president
and Rep. Norwood reached an agreement on the contentious
issue of health plan liability on the eve of the
House vote. The White House had felt is was especially
important to target Rep. Norwood, who has been
a leader on this issue for several years and the
person that several Republicans looked to for
guidance on this issue.
Rep.
Norwood reached the deal with President Bush without
the support of his primary congressional allies
in the fight over managed care reform after repeatedly
stating that he would not make any deal without
running it past his bipartisan coalition of supporters.
Rep. Norwood's previous supporters in this effort,
including Reps. Ganske, Dingell, and Berry, bitterly
opposed this compromise, arguing that it rendered
the patient protections contained in the bill
almost meaningless.
The
Norwood-Bush compromise amendment narrowly passed
the House by a party-line vote of 218-213, and
the final bill passed 226-203. The House and Senate
bills now move to what promises to be an extremely
contentious conference committee. It is important
to note that despite the passage of compromise
liability provisions the House bill did adopt
a strong set of patient protections that are largely
identical to the Senate legislation. This represents
a major step forward. However, deep partisan disagreements
over the liability and several tax provisions
still exist. ATRA will remain a player during
these negotiations, and we will keep you updated
as the conference committee proceeds.
Family
Opportunity Act
Congress
has yet to take any action on the Family Opportunity
Act ("FOA"). Although the bill has 71
Senate cosponsors, including a majority of the
Finance Committee membership, which has jurisdiction
over the bill, 198 House cosponsors, and funds
reserved in the FY 2002 budget resolution, it
still awaits congressional action.
In
the Senate, it appears this delay may be due to
certain Finance Committee members holding the
FOA "hostage" until they can secure
action on a larger bill designed to decrease the
number of uninsured Americans. Finance Committee
ranking member Charles Grassley (R-IA), the bill's
primary sponsor in the Senate, planned to offer
the FOA as an amendment during a scheduled Finance
Committee markup in an effort force a vote on
the bill. However, the markup was cancelled, meaning
any action on FOA will not take place until after
the August congressional recess. ATRA will monitor
the status of the Family Opportunity Act and will
stand ready to mobilize its grassroots in support
of the bill as appropriate.
Rehabilitation
PPS
On
August 7, the Centers for Medicare and Medicaid
Services ("CMS" - formerly HCFA) published
the final regulation describing the prospective
payment system ("PPS") for inpatient
rehabilitation facilities ("IRF"). The
final PPS is notably different from the proposed
inpatient rehabilitation PPS CMS unveiled in November
2000. ATRA submitted written comments in December
2000 to CMS that described its primary concerns.
These concerns were related to the use of the
MDS PAC as the patient assessment instrument and
the potential expansion of the transfer policy
to home care or outpatient rehabilitation care.
In
the final rule, CMS announced that it will use
a modified version of the Functional Independence
Measure ("FIM") as the patient assessment
instrument, replacing the MDS PAC, which was to
be the patient assessment instrument under the
November 3, 2000 proposed rule. In addition, CMS
decided "to allow any clinician who is employed
by the IRF or is a contract clinician of the IRF,
and who has been trained in how to perform a patient
assessment using our assessment instrument, to
perform a patient assessment and record data for
any item on the patient assessment instrument"
(66 FR 41328). This is a major improvement over
the proposed rule, which precluded recreational
therapists from filling out the patient assessment
instrument.
CMS
also decided that "it would be inappropriate
to expand the transfer policy at this time to
include discharges of patients who will receive
home health and outpatient therapy services"
(66 FR 41354).
These
developments represent major victories for ATRA,
as it opposed both the use of the MDS-PAC as the
patient assessment instrument and the extension
of the transfer policy to home health care or
outpatient rehabilitation services. These final
regulations are effective January 1, 2002.
FY
2002 Appropriations
The
annual appropriations process remains on hold
as Congress prepares for what promises to be a
bruising budget battle this fall. Neither the
House nor Senate Appropriations Committees have
begun work on the bill funding the Departments
of Labor, Health and Human Services, and Education.
They should begin work on these bills in September.
Recently
released budget figures greatly complicate matters.
The Congressional Budget Office released a report
on August 27 projecting a $153 billion surplus
for FY 2001. When the Social Security surplus
is removed, however, CBO estimates that the government
will have to use about $9 billion in funds collected
for Social Security in order to balanced the budget.
CBO predicts a tiny $2 billion surplus in FY 2002
and an $18 billion deficit in FY 2003 (not including
the surpluses generated by Social Security).
This
means that lawmakers will either have to exceed
the budget caps in order to increase discretionary
spending or dip into the Social Security surplus,
which is a politically perilous decision that
each side is either to blame the other for causing.
Democrats argue that President Bush's large tax
cut used up the entire surplus, while the White
House and congressional Republicans will blame
reckless spending by Democrats.
Either
way, the appropriations battle should be highly
contentious. This process should continue into
at least November.
Medicare
Reform/Prescription Drugs
Although
it is perhaps the most important healthcare issue
facing Congress today, lawmakers have yet to address
legislation to either add an outpatient prescription
drug benefit to the Medicare program or fundamentally
reform the program. Although it is unlikely that
Congress will act on such legislation before the
end of the 1st session, the second half of the
107th Congress may see some action in this area
throughout the first half of 2002. Most likely
is the prospect that the 107th Congress will not
be able to produce a significant Medicare reform
bill that President Bush will sign.
Senate
Finance Committee Chairman Max Baucus (D-MT) has
indicated that his committee, which had planned
to mark up Medicare reform/prescription drug legislation
before the August recess, will now likely consider
such legislation in September. He recently stated
that he wants to use all $300 billion that was
set aside in the FY 2002 budget resolution solely
to add an outpatient prescription drug benefit
to Medicare and not for structural Medicare reform.
These funds will only become available if the
Finance Committee in the Senate or the Ways and
Means or Energy and Commerce Committees in the
House report out a bill.
Chairman
Baucus stated his desire to use the entire reserve
fund for a drug benefit in response to the introduction
of a set of Medicare reform proposals introduced
by an influential group of Finance Committee members,
including Senators John Breaux (D-LA), Charles
Grassley (R-IA), Olympia Snowe (R-ME), Orrin Hatch
(R-UT), and James Jeffords (I-VT). He said the
plan "does not represent a broad majority
in the Senate, and I cannot support it, and I
will actively oppose it. It's robbery, not reform."
While
Chairman Baucus opposes this proposal, it was
introduced by an influential group of Finance
Committee members and may have some traction in
committee. Regardless, lawmakers will need to
address these issues in the near future. ATRA
will continue to monitor the developments and
update members as appropriate. (Note: for a detailed
analysis of competing Medicare reform/prescription
drug proposals, please see Attachment
A).
Prepared
by:
Peter Thomas, Legislative Counsel, American Therapeutic
Recreation Association
Jeremy Allen, Legislative Director, Powers, Pyles,
Sutter & Verville, PC
August 31, 2001